Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.
Virion Therapeutics has raised $95K in total funding. The most recent round was Undisclosed. The last funding was announced in October 2024.
Virion Therapeutics's investors include Keiretsu Capital, Life Science Angels, Mid Atlantic Bio Angels, Keiretsu Forum, Puget Sound Venture Club.
Virion Therapeutics is headquartered in Newark, United States.
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.
Virion Therapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Virion Therapeutics — Funding & Investors." VCBacked, October 1, 2024, https://www.vcbacked.co/company/virion-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Virion Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/virion-therapeutics
{{cite web |title=Virion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/virion-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated